Page last updated: 2024-10-15

insulin, (2-nitro-4-azidophenylacetyl)(b2)-des-phe(b1)-

Description

insulin, (2-nitro-4-azidophenylacetyl)(B2)-des-Phe(B1)-: labeled with 125I [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID129010897
MeSH IDM0108651

Synonyms (9)

Synonym
napa-insulin (b29)
insulin, (2-nitro-4-azidophenylacetyl)(b2)-des-phe(b1)-
b2-(2-nitro-4-azidophenylacetyl)-(b1)-des-phe-insulin
insulin, (2-nitro-4-azidophenylacetyl)(b2)-desphenylalanine(b1)-
76688-14-7
b2-(2-nitro-4-azidophenylacetyl)-b1-desphenylalanine-insulin
2-nitro-4-azidophenylacetyl (b2)des-phenylalanyl (b1)insulin
napa-dp-insulin
insulin, 1b-de-l-phenylalanine-2b-(n-((4-azido-2-nitrophenyl)acetyl)-l-valine)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (94.44)18.7374
1990's1 (5.56)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (15.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (85.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]